期刊文献+

脱细胞猪角膜基质的生物相容性与组织工程化兔角膜上皮移植的研究 被引量:6

Btocompatibility of acellular corneal stroma and transplantation of tissue-engineered corneal epithelium
原文传递
导出
摘要 目的探讨脱细胞猪角膜基质的生物相容性,评价组织工程化角膜上皮组织作供体的可行性,观察支架材料的细胞化情况和种子细胞的存活情况。方法实验研究。采用完全随机化设计的方法,用Dispase-Triton—X-100处理猪角膜基质,脱去角膜细胞;以角膜基质囊袋内植入的方法,观察异种角膜基质植入后的生物相容性,A组:脱细胞猪角膜基质,B组:新鲜猪角膜基质,C组:空白对照组。以组织工程化雄性角膜上皮组织为供体,同种雌性为受体,作板层角膜移植,观察角膜的混浊、水肿、新生血管等情况;组织病理学和免疫组化方法检测支架材料的细胞化情况,Y染色体性别决定基因(SRY)-聚合酶链反应(PCR)方法追踪种子细胞的存活情况。结果猪角膜基质植入兔角膜囊袋后,角膜逐渐恢复透明,排斥反应指数〈6,组织病理学观察角膜结构完整,胶原纤维平行排列,少许细胞长入脱细胞猪角膜基质边缘,各组免疫组化检测未见CD4+、CD8+T淋巴细胞浸润。组织工程化角膜上皮作异体板层角膜移植后,3~4d上皮光滑,10~20d变为透明;15d时角膜上皮、基质、内皮完整,上皮细胞约4或5层结构,少许基质细胞长入支架,1个月时可见角膜上皮细胞约7或8层细胞,基质纤维排列规则,多量细胞长入脱细胞角膜基质。上皮细胞表达CK3,支架内新生细胞表达波形蛋白。SRY-PCR结果显示种子细胞可以在受体内长期存活。结论脱细胞猪角膜基质生物相容性良好,组织工程化角膜上皮可作为板层角膜移植的供体,脱细胞猪角膜基质细胞化良好,种子细胞可以在受体内长期存活。 Objective To evaluate the biocompatibility of xenogeneic acellular corneal stroma, the feasibility of tissue engineered corneal epithelial transplantation, and verify the long term survival of epithelial allograft. Methods It was a experimental study. Porcine corneal stroma was treated by dispase followed by Triton-X-100 detergent. Treated porcine corneal stroma ( group A) or fresh corneal stroma ( group B) were put into the sac of rabbit cornea. Rabbit cornea without implantation of porcine corneal stroma was used as the control group ( group C). Immunological rejection was evaluated in morphology, histopathology and immunohistochemistry in month 1,3, 6. Female rabbit underwent lamellar keratoplasty (LK) using male tissue engineered corneal epithelium as donors, and immunological rejection after LK was analyzed. The corneas were collected at day I, 3, 7, 15 and 30 after LK and evaluated by histopathology, immunohistocbemistry and sex-determining region of Y-chromosome ( SRY ) -PCR analysis. Results All corneas became transparent gradually after the transplantation of treated porcine corneal stroma and were not rejected. The epithelium, stroma, endothelium, Bowman's and Descemet's membrane were preserved in all corneas of group A and B in histological observations, collagen fibers were parallel, a few keratocytes presented in the acellular and fresh corneal stromas. The corneas of group C were normal in histological sections. No significant immune rejection was noted in any of the corneas. The corneas in the study of transplantation of tissue engineered cornea epithelium recovered smoothly in 3 or 4 days, turned transparent in 15 or 20 days after surgery and were not stained by fluorescein. Well-differentiated corneal epithelium were recognized at 15 and 30 days after LK. Many keratocytes infiltrated into the scaffold. SRY-PCR analysis showed that allogenic donor corneal epithelium cells could survive in recipients after a long-term observation. Conclusions Acellular porcine corneal stroma
出处 《中华眼科杂志》 CAS CSCD 北大核心 2008年第10期934-942,共9页 Chinese Journal of Ophthalmology
基金 山东省优秀中青年科学家科研奖励基金(03BS018)
关键词 角膜基质 角膜上皮 组织工程 角膜移植 细胞存活 Corneal stroma Epithelium, corneal Tissue engineer Corneal transplantion Cell survival
  • 相关文献

参考文献12

二级参考文献46

  • 1唐娜,李辰,徐锦堂.穿透性角膜移植术后抗角膜内皮抗原抗体的检测[J].中华眼科杂志,1996,32(4):252-254. 被引量:4
  • 2何宇光 陈任 等.实验性异种板层角膜移植的免疫学研究[J].眼科研究,1987,5:157-160. 被引量:1
  • 3Waldock A, Cook SD. Corneal transplantation: how successful are we? Br J Ophthalmol, 2000, 84: 813-815. 被引量:1
  • 4Bertelmann E, Jaroszewski J, Pleyer UWE. Corneal allograft rejection: current understanding. 2. Clinical implications. Ophthalmologica, 2002, 216: 2-12. 被引量:1
  • 5Neubaus P, Klupp J, Langrebr JM. mTOR inhibitors: an overview. Liv Transplanta, 2001, 7:473-484. 被引量:1
  • 6Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation, 2001, 72: 1181-1193. 被引量:1
  • 7Holland EJ, Chan CC, Wetzig RP, et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea, 1991, 10: 374-380. 被引量:1
  • 8Niederkorn JY. Mechanisms of corneal graft rejection: the sixth annual thygeson lecture, presented at the ocular microbiology and immunology group meeting, October 21, 2000. Cornea, 2001, 20: 675-679. 被引量:1
  • 9MacDonald AS. A worldwide, phase Ⅲ, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation, 2001, 71: 271-280. 被引量:1
  • 10Tian L, Lu L, Yuan Z, et al. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Transplantation, 2004, 77:183-189. 被引量:1

共引文献91

同被引文献62

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部